High Tech Leads a Turning Point in the December PMI2025-12-31
As the year 2025 draws to a close, the final economic reports from Beijing offer a surprising sense of resilience. For much of the past twelve months, the prevailing narrative surrounding the world’s second-largest economy has been one of managed decline or persistent stagnation. Yet the latest data from the National Bureau of Statistics and the China Federation of Logistics and Purchasing suggests that the manufacturing sector has finished the year on a much firmer footing than many had predicted.
Pakistan-China Business Forum Opens Sub-Branch in Hangzhou2025-12-29
The Sub-branch of the Pakistan-China Business Forum (PCBF) was recently inaugurated in Hangzhou, Zhejiang province, marking a step forward to deepen economic and trade cooperation between China and Pakistan within the Yangtze River Delta (YRD) region.
China's Mobile Payment Ecosystem Offers Seamless Experience to Global Visitors2025-12-28
As the afternoon light bathed the ancient eaves of Nanjing's Confucius Temple Scenic Area, Hugo from France navigated the bustling streets with remarkable ease. During his first visit to China, with scheduled visits to Wuhan and Shenyang, he spoke highly of the nation's seamlessly integrated digital ecosystem.
Pakistan's Seafood Exports to China Surge by 24% in 20252025-12-28
Pakistan's seafood exports to China experienced a robust 24% increase from January to November 2025, reaching an approximate value of $235.7 million in the first eleven months of 2025, compared to $188.95 million during the same period in 2024, according to data from the General Administration of Customs of China (GACC).
9th China-Pakistan Economic Corridor Media Forum convenes2025-12-25
The 9th China-Pakistan Economic Corridor (CPEC) Media Forum was held in a hybrid format (online + offline) in Islamabad and Beijing on December 24. With the theme "Strengthen Media Cooperation, Advance the Construction of the Upgraded Version 2.0 of CPEC", the forum was hosted by the Chinese Embassy in Pakistan and co-organized by China Economic Net and Pakistan-China Institute.
China, Pakistan Sign Package of MoUs to Deepen Industry Education Integration in Vocational Training2025-12-25
China and Pakistan on Tuesday signed a package of cooperation documents and launched joint programs to advance vocational education, with a focus on integrating industry needs with skills training. The agreements were announced at the "Seminar on International Cooperation and Exchange: Integration of Industry and Education in Vocational Education between China and Pakistan" held in Beijing.
Chinese-Made Intravenous Immunoglobulin (pH4) Approved for Sale in Pakistan2025-12-25
BEIJING, Dec. 25 (China Economic Net) - Guangdong Shuanglin Bio-pharmacy Co., Ltd., a subsidiary of PLBIO, has secured regulatory approval from Pakistan for its Intravenous Immunoglobulin (pH4), a key blood-derived therapeutic product widely used in clinical practice, its parent company announced on Wednesday in response to investor inquiries.
The drug registration certificate was jointly issued by Pakistan’s Ministry of National Health Services, Regulations, and Coordination and the Drug Regulatory Authority of Pakistan. This approval enables expanded access in Pakistan to advanced biotherapeutic options, particularly for treating immune-related disorders.
The company has entered into an Exclusive Licensing and Supply Agreement with local distributor 3A Diagnostics, facilitating the product’s market entry. It noted that while the medicine is now available locally, no plasmapheresis centers have been established in Pakistan.
Intravenous Immunoglobulin (pH4) is a sterile, purified preparation derived from pooled human plasma, primarily containing IgG antibodies. It plays a vital role in replacing deficient antibodies in patients with immune disorders and in modulating abnormal immune responses in autoimmune conditions.
The introduction of this WHO-standard product strengthens Pakistan's clinical capacity to manage conditions such as primary immunodeficiencies, autoimmune diseases, and severe infections. The partnership also supports the resilience of Pakistan's pharmaceutical supply chain and aligns with efforts to diversify sources of essential medicines, contributing to public health infrastructure and bilateral healthcare cooperation between China and Pakistan.